Human platelet lysate successfully promotes proliferation and subsequent chondrogenic differentiation of adipose-derived stem cells: A comparison with articular chondrocytes

Journal of Tissue Engineering and Regenerative Medicine

Volumn 9, Issue 7, 2015, Pages 808-818

  Hildner, F ^a,c   Eder, M J ^a,c   Hofer, K ^a,c   Aberl, J ^a,c   Redl, H ^b,c   van Griensven, M ^b,c   Gabriel, C ^a,c   Peterbauer Scherb, A ^a,c  

^a Red Cross Blood Transfusion Service of Upper Austria   (Austria)

^b LUDWIG BOLTZMANN INSTITUTE FOR EXPERIMENTAL AND CLINICAL TRAUMATOLOGY   (Austria)

^c AUSTRIAN CLUSTER FOR TISSUE REGENERATION   (Austria)

Author keywords

Adipose derived stem cells; Cartilage; Chondrogenic differentiation; Fetal calf serum; Human platelet lysate; PRP

Indexed keywords

CELL CULTURE; COLLAGEN; EXPANSION; GLYCOPROTEINS; PLASMA (HUMAN); PLATELETS; STEM CELLS;

ADIPOSE DERIVED STEM CELLS; ARTICULAR CHONDROCYTES; CHONDROGENIC DIFFERENTIATION; FOETAL CALF SERUMS; GOLD STANDARDS; HUMAN ARTICULAR CHONDROCYTES; HUMAN PLATELET LYSATE; PLATELET LYSATE; POTENTIAL RISKS; PRP;

CARTILAGE;

COLLAGEN TYPE 10; COLLAGEN TYPE 2; GLYCOSAMINOGLYCAN; MITOGEN ACTIVATED PROTEIN KINASE; THROMBOCYTE CONCENTRATE; TRANSCRIPTION FACTOR SOX9;

ADIPOSE DERIVED STEM CELL; ARTICLE; CARTILAGE CELL; CELL CULTURE; CELL DIFFERENTIATION; CELL EXPANSION; CELL ISOLATION; CELL LYSATE; CELL POPULATION; CELL PROLIFERATION; CHONDROGENESIS; CONTROLLED STUDY; FETAL CALF SERUM; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMMUNITY; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; THROMBOCYTE; ADIPOSE TISSUE; ARTICULAR CARTILAGE; CHEMISTRY; COMPARATIVE STUDY; CYTOLOGY; METABOLISM; STEM CELL;

ADIPOSE TISSUE; BLOOD PLATELETS; CARTILAGE, ARTICULAR; CELL DIFFERENTIATION; CHONDROCYTES; CHONDROGENESIS; HUMANS; STEM CELLS;

EID: 84957851835     PISSN: 19326254     EISSN: 19327005     Source Type: Journal    
DOI: 10.1002/term.1649     Document Type: Article

References (51)

1. Akeda K, An HS, Okuma M, et al. 2006; Platelet-rich plasma stimulates porcine articular chondrocyte proliferation and matrix biosynthesis. Osteoarthr Cartilage 14: 1272-1280.
2. Anitua E, Sanchez M, Nurden AT, et al. 2007; Reciprocal actions of platelet-secreted TGFβ1 on the production of VEGF and HGF by human tendon cells. Plast Reconstr Surg 119: 950-959.
3. Bell DM, Leung KK, Wheatley SC, et al. 1997; SOX9 directly regulates the type-II collagen gene. Nat Genet 16: 174-178.
4. Castegnaro S, Chieregato K, Maddalena M, et al. 2011; Effect of platelet lysate on the functional and molecular characteristics of mesenchymal stem cells isolated from adipose tissue. Curr Stem Cell Res Ther 6: 105-114.
5. Christgau M, Moder D, Hiller KA, et al. 2006; Growth factors and cytokines in autologous platelet concentrate and their correlation to periodontal regeneration outcomes. J Clin. Periodontol 33: 837-845.
6. Cognasse F, Boussoulade F, Chavarin P, et al. 2006; Release of potential immunomodulatory factors during platelet storage. Transfusion 46: 1184-1189.
7. Doucet C, Ernou I, Zhang Y, et al. 2005; Platelet lysates promote mesenchymal stem cell expansion: a safety substitute for animal serum in cell-based therapy applications. J Cell Physiol 205: 228-236.
8. Drengk A, Zapf A, Sturmer EK, et al. 2009; Influence of platelet-rich plasma on chondrogenic differentiation and proliferation of chondrocytes and mesenchymal stem cells. Cells Tissues Organs 189: 317-326.
9. Estes BT, Wu AW, Storms RW, et al. 2006; Extended passaging, but not aldehyde dehydrogenase activity, increases the chondrogenic potential of human adipose-derived adult stem cells. J Cell Physiol 209: 987-995.
10. Frechette JP, Martineau I, Gagnon G. 2005; Platelet-rich plasmas: growth factor content and roles in wound healing. J Dent Res 84: 434-439.
11. Gaissmaier C, Fritz J, Krackhardt T, et al. 2005; Effect of human platelet supernatant on proliferation and matrix synthesis of human articular chondrocytes in monolayer and three-dimensional alginate cultures. Biomaterials 26: 1953-1960.
12. Giovannini S, az-Romero J, Aigner T, et al. 2010; Population doublings and percentage of S100-positive cells as predictors of in vitro chondrogenicity of expanded human articular chondrocytes. J Cell Physiol 222: 411-420.
13. Gruber R, Karreth F, Kandler B, et al. 2004; Platelet-released supernatants increase migration and proliferation, and decrease osteogenic differentiation of bone marrow-derived mesenchymal progenitor cells under in vitro conditions. Platelets 15: 29-35.
14. Gruber R, Varga F, Fischer MB, et al. 2002; Platelets stimulate proliferation of bone cells: involvement of platelet-derived growth factor, microparticles and membranes. Clin Oral Implants Res 13: 529-535.
15. Heldin CH, Miyazono K, Ten DP. 1997; TGFβ signalling from cell membrane to nucleus through SMAD proteins. Nature 390: 465-471.
16. Hennig T, Lorenz H, Thiel A, et al. 2007; Reduced chondrogenic potential of adipose tissue derived stromal cells correlates with an altered TGFβ receptor and BMP profile and is overcome by BMP-6. J Cell Physiol 211: 682-691.
17. Hildner F, Peterbauer A, Wolbank S, et al. 2010; FGF-2 abolishes the chondrogenic effect of combined BMP-6 and TGFβ in human adipose derived stem cells. J Biomed Mater Res A 94: 978-987.
18. Huang JI, Zuk PA, Jones NF, et al. 2004; Chondrogenic potential of multipotential cells from human adipose tissue. Plast Reconstr Surg 113: 585-594.
19. Johnstone B, Hering TM, Caplan AI, et al. 1998; In vitro chondrogenesis of bone marrow-derived mesenchymal progenitor cells. Exp Cell Res 238: 265-272.
20. Kadri N, Potiron N, Ouary M, et al. 2007; Fetal calf serum-primed dendritic cells induce a strong anti-fetal calf serum immune response and diabetes protection in the non-obese diabetic mouse. Immunol Lett 108: 129-136.
21. Kandler B, Fischer MB, Watzek G, et al. 2004; Platelet-released supernatant increases matrix metalloproteinase-2 production, migration, proliferation, and tube formation of human umbilical vascular endothelial cells. J Periodontol 75: 1255-1261.
22. Kaps C, Loch A, Haisch A, et al. 2002a; Human platelet supernatant promotes proliferation but not differentiation of articular chondrocytes. Med Biol Eng Comput 40: 485-490.
23. Kaps C, Loch A, Haisch A, et al. 2002b; Human platelet supernatant promotes proliferation but not differentiation of articular chondrocytes. Med Biol Eng Comput 40: 485-490.
24. Kim YJ, Sah RL, Doong JY, et al. 1988; Fluorometric assay of DNA in cartilage explants using Hoechst 33258. Anal Biochem 174: 168-176.
25. Kocaoemer A, Kern S, Kluter H, et al. 2007; Human AB serum and thrombin-activated platelet-rich plasma are suitable alternatives to fetal calf serum for the expansion of mesenchymal stem cells from adipose tissue. Stem Cells 25: 1270-1278.
26. Kretzschmar M, Doody J, Massague J 1997; Opposing BMP and EGF signalling pathways converge on the TGFβ family mediator Smad1. Nature 389: 618-622.
27. Marx RE. 2001; Platelet-rich plasma (PRP): what is PRP and what is not PRP? Implant Dent 10: 225-228.
28. Marx RE, Carlson ER, Eichstaedt RM, et al. 1998; Platelet-rich plasma: Growth factor enhancement for bone grafts. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 85: 638-646.
29. Mishra A, Pavelko T. 2006; Treatment of chronic elbow tendinosis with buffered platelet-rich plasma. Am J Sports Med 34: 1774-1778.
30. Okuda K, Kawase T, Momose M, et al. 2003; Platelet-rich plasma contains high levels of platelet-derived growth factor and transforming growth factor-β and modulates the proliferation of periodontally related cells in vitro. J Periodontol 74: 849-857.
31. Oyama T, Nishimoto S, Tsugawa T, et al. 2004; Efficacy of platelet-rich plasma in alveolar bone grafting. J Oral Maxillofac Surg 62: 555-558.
32. Pera EM, Ikeda A, Eivers E, et al. 2003; Integration of IGF, FGF, and anti-BMP signals via Smad1 phosphorylation in neural induction. Genes Dev 17: 3023-3028.
33. Pietrzak WS, Eppley BS. 2005. Platelet rich plasma: biology and new technology. J Craniofac Surg 16: 1043-1054.
34. Ploderl K, Strasser C, Hennerbichler S, et al. 2011; Development and validation of a production process of platelet lysate for autologous use. Platelets 22: 204-209.
35. Rauch C, Feifel E, Amann EM, et al. 2011; Alternatives to the use of fetal bovine serum: human platelet lysates as a serum substitute in cell culture media. ALTEX 28: 305-316.
36. Sapkota G, Alarcon C, Spagnoli FM, et al. 2007; Balancing BMP signaling through integrated inputs into the Smad1 linker. Mol Cell 25: 441-454.
37. Schallmoser K, Bartmann C, Rohde E, et al. 2007; Human platelet lysate can replace fetal bovine serum for clinical-scale expansion of functional mesenchymal stromal cells. Transfusion 47: 1436-1446.
38. Schnabel M, Marlovits S, Eckhoff G, et al. 2002; Dedifferentiation-associated changes in morphology and gene expression in primary human articular chondrocytes in cell culture. Osteoarthr Cartilage 10: 62-70.
39. Shen EC, Chou TC, Gau CH, et al. 2006; Releasing growth factors from activated human platelets after chitosan stimulation: a possible biomaterial for platelet-rich plasma preparation. Clin Oral Implants Res 17: 572-578.
40. Shih DT, Chen JC, Chen WY, et al. 2011; Expansion of adipose tissue mesenchymal stromal progenitors in serum-free medium supplemented with virally inactivated allogeneic human platelet lysate. Transfusion 51: 770-778.
41. Spees JL, Gregory CA, Singh H, et al. 2004; Internalized antigens must be removed to prepare hypoimmunogenic mesenchymal stem cells for cell and gene therapy. Mol Ther 9: 747-756.
42. Spreafico A, Chellini F, Frediani B, et al. 2009; Biochemical investigation of the effects of human platelet releasates on human articular chondrocytes. J Cell Biochem 108: 1153-1165.
43. Tuschong L, Soenen SL, Blaese RM, et al. 2002; Immune response to fetal calf serum by two adenosine deaminase-deficient patients after T cell gene therapy. Hum Gene Ther 13: 1605-1610.
44. Vacanti V, Kong E, Suzuki G, et al. 2005; Phenotypic changes of adult porcine mesenchymal stem cells induced by prolonged passaging in culture. J Cell Physiol 205: 194-201.
45. Weibrich G, Kleis WK, Hafner G, et al. 2002; Growth factor levels in platelet-rich plasma and correlations with donor age, sex, and platelet count. J Craniomaxillofac Surg 30: 97-102.
46. Wolbank S, Peterbauer A, Fahrner M, et al. 2007; Dose-dependent immunomodulatory effect of human stem cells from amniotic membrane: a comparison with human mesenchymal stem cells from adipose tissue. Tissue Eng 13: 1173-1183.
47. Yamashita S, Andoh M, Ueno-Kudoh H, et al. 2009; Sox9 directly promotes Bapx1 gene expression to repress Runx2 in chondrocytes. Exp Cell Res 315: 2231-2240.
48. Zaky SH, Ottonello A, Strada P, et al. 2008; Platelet lysate favours in vitro expansion of human bone marrow stromal cells for bone and cartilage engineering. J Tissue Eng Regen Med 2: 472-481.
49. Zhou G, Zheng Q, Engin F, et al. 2006; Dominance of SOX9 function over RUNX2 during skeletogenesis. Proc Natl Acad Sci USA 103: 19004-19009.
50. Zimmermann R, Arnold D, Strasser E, et al. 2003; Sample preparation technique and white cell content influence the detectable levels of growth factors in platelet concentrates. Vox Sang 85: 283-289.
51. Zuk PA, Zhu M, Mizuno H, et al. 2001; Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng 7: 211-228.